Wild-type LRRK2 as a new potential therapeutic target in idiopathic Parkinson's disease.
作者信息
Sanjari Moghaddam Hossein, Aarabi Mohammad Hadi
机构信息
Neurology division, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
ImmunoPharmacology Network (IPhoNe), Universal Scientific Education and Research Network (USERN), Tehran, Iran.
出版信息
Mov Disord. 2018 Dec;33(12):1876. doi: 10.1002/mds.27509. Epub 2018 Nov 19.
PMID:30452792
Abstract
摘要
Zotero 插件